Tumor Cell Contamination of Bone Marrow Harvest Products: Clinical Consequences in a Cohort of Advanced-Stage Breast Cancer Patients Undergoing High-Dose Chemotherapy-Reference-Cited by-同舟云学术

Tumor Cell Contamination of Bone Marrow Harvest Products: Clinical Consequences in a Cohort of Advanced-Stage Breast Cancer Patients Undergoing High-Dose Chemotherapy

Published:1996-12 Issue:6 Volume:5 Page:617-624
ISSN:1061-6128
Container-title:Journal of Hematotherapy
language:en
Short-container-title:Journal of Hematotherapy

Author:

BROCKSTEIN BRUCE E.,ROSS AMY A.,MOSS THOMAS J.,KAHN DOUGLAS G.,HOLLINGSWORTH KRISTI,WILLIAMS STEPHANIE F.

Publisher

Mary Ann Liebert Inc

Subject

Hematology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.1.1996.5.617

Reference26 articles.

1. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]

2. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells

3. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

4. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique

5. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells;Biology of Blood and Marrow Transplantation;2012-01

2. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer;Bone Marrow Transplantation;2007-11-26

3. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients;Journal of Photochemistry and Photobiology B: Biology;2002-11

4. Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: Predictors and clinical relevance;Biology of Blood and Marrow Transplantation;2002-10

5. High‐dose mitoxantrone and cyclophosphamide without stem cell support in patients with high‐risk and advanced breast carcinoma;Cancer;2001-10-31